[Therapy of granuloma gangraenescens].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D004194:Disease; D005145:Face; D006099:Granuloma / Q000628:therapy*; D006103:Granuloma, Lethal Midline; D006801:Humans; D011878:Radiotherapy; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D000324:Adrenocorticotropic Hormone
ACTH/therapeutic use; ANTIBIOTICS/therapeutic use; FACE/diseases; GRANULOMA/therapy; RADIOTHERAPY; SULFONAMIDES/therapeutic use
Zur Behandlung des Granuloma gangraenescens.